Roulston J E, Wathen C G, Muir A L
Scott Med J. 1986 Oct;31(4):234-8. doi: 10.1177/003693308603100405.
Nifedipine has been used in the management of hypertension in 36 consecutive patients who could not tolerate, or were not controlled by, atenolol and thiazide diuretics. Mean supine blood pressure was reduced from 193/110 +/- 5/2 (SEM) mmHg to 162/91 +/- 5/2 mmHg at eight weeks and remained at that level for the six months of follow-up. Blood pressure reduction at four weeks was not always a predictor of final BP level. Eight patients could not tolerate atenolol, nine patients could not tolerate thiazide diuretics and four patients could not tolerate nifedipine. No significant changes in plasma urea, creatinine, sodium, potassium urate, 'total CO2' or glucose were observed. We conclude that nifedipine is a well-tolerated drug and may be useful after beta-blockers and thiazide have been tried in the management of hypertension.
硝苯地平已用于连续36例不能耐受阿替洛尔和噻嗪类利尿剂或使用这些药物血压控制不佳的高血压患者的治疗。八周时,平均仰卧位血压从193/110±5/2(标准误)mmHg降至162/91±5/2 mmHg,并在六个月的随访期内维持在该水平。四周时的血压降低并不总是最终血压水平的预测指标。8例患者不能耐受阿替洛尔,9例患者不能耐受噻嗪类利尿剂,4例患者不能耐受硝苯地平。未观察到血浆尿素、肌酐、钠、钾、尿酸、“总二氧化碳”或葡萄糖有显著变化。我们得出结论,硝苯地平耐受性良好,在β受体阻滞剂和噻嗪类药物治疗高血压效果不佳时可能有用。